TP53 and breast carcinoma: Due to the large proportion of breast carcinomas retaining wt-p53, radiotherapy and chemotherapy agents such as doxorubicin are successful in reactivating p53 via the DNA damage pathway, inducing cell cycle arrest and cell death [25,26,27].